Powered by

Washington University, Sage Therapeutics Assigned Patent for Pharmaceutical Compositions

Jul 11, 2019 - Targeted News Service

ALEXANDRIA, Va., July 11 -- Washington University, St. Louis, Missouri, and Sage Therapeutics, Cambridge, Massachusetts, have been assigned a patent (No. 10,342,809, initially filed March 15, 2017) developed by two co-inventors for "neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same." The co-inventors are Douglas Covey, St. Louis, Missouri, and Albert Jean Robichaud, Ringoes, New Jersey.

The full-text of the patent can be found at http://pa...